Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections

Documenti analoghi

• Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis
  di: Hisert, Katherine B., et al.
  Pubblicazione: (2016)
• Cystic Fibrosis Transmembrane Conductance Regulator and Pseudomonas
  di: Zemanick, Edith T., et al.
  Pubblicazione: (2014)
• Ivacaftor-induced sweat chloride reductions correlate with increases in airway surface liquid pH in cystic fibrosis
  di: Alaiwa, Mahmoud H. Abou, et al.
  Pubblicazione: (2018)
• Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities
  di: Adam, Ryan J., et al.
  Pubblicazione: (2016)
• Macrophage Migration Inhibitory Factor Enzymatic Activity, Lung Inflammation, and Cystic Fibrosis
  di: Adamali, Huzaifa, et al.
  Pubblicazione: (2012)